3 European Stocks Estimated To Be Undervalued In October 2025

In October 2025, the European stock market is experiencing a notable upswing, with the pan-European STOXX Europe 600 Index reaching record levels driven by a rally in technology stocks and expectations for lower U.S. borrowing costs. Amid this positive sentiment, investors are keenly looking for opportunities to identify undervalued stocks that could offer potential value as they navigate through an environment of contained inflation and slightly rising unemployment rates in the eurozone. In such a climate, identifying undervalued stocks involves assessing companies with strong fundamentals that may not yet be fully recognized by the market, presenting potential opportunities for growth as broader economic conditions improve.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name	Current Price	Fair Value (Est)	Discount (Est)
Xplora Technologies (OB:XPLRA)	NOK43.50	NOK85.09	48.9%
Vimi Fasteners (BIT:VIM)	€1.19	€2.32	48.8%
SBO (WBAG:SBO)	€27.35	€53.33	48.7%
Robit Oyj (HLSE:ROBIT)	€1.14	€2.19	48.1%
Micro Systemation (OM:MSAB B)	SEK63.40	SEK122.68	48.3%
Lingotes Especiales (BME:LGT)	€5.70	€11.11	48.7%
Industrie Chimiche Forestali (BIT:ICF)	€6.40	€12.59	49.1%
E-Globe (BIT:EGB)	€0.65	€1.26	48.5%
Atea (OB:ATEA)	NOK142.20	NOK280.38	49.3%
Allegro.eu (WSE:ALE)	PLN33.615	PLN66.29	49.3%

Click here to see the full list of 208 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Hanza (OM:HANZA)

Overview: Hanza AB (publ) offers manufacturing solutions and has a market cap of SEK4.85 billion.

Operations: The company's revenue segments include Main Markets at SEK3.11 billion, Other Markets at SEK2.16 billion, and Business Development and Services contributing SEK32 million.

Estimated Discount To Fair Value: 34.5%

Hanza's recent earnings report shows significant growth, with net income rising to SEK 52 million in Q2 2025 from SEK 6 million a year ago. Despite substantial insider selling, the company is trading at SEK105.6, well below its estimated fair value of SEK161.32, and is considered highly undervalued based on discounted cash flows. While revenue growth is slower than ideal at 12.6% per year, earnings are expected to grow significantly above market rates at 34.6% annually over the next three years.

• Upon reviewing our latest growth report, Hanza's projected financial performance appears quite optimistic.
• Get an in-depth perspective on Hanza's balance sheet by reading our health report here.

KB Components (OM:KBC)

Overview: KB Components AB (publ) is a company that designs, develops, manufactures, and sells polymer components for various sectors including light and heavy vehicles, medical, furniture, lighting, chrome plating, and industrial applications both in Sweden and internationally; it has a market cap of SEK2.38 billion.

Operations: The company's revenue segments are distributed as follows: SEK120.74 million from Asia, SEK1.18 billion from Europe, and SEK1.59 billion from North America.

Estimated Discount To Fair Value: 46.4%

KB Components is trading at SEK42.5, significantly below its estimated fair value of SEK79.31, indicating it is undervalued based on discounted cash flows. The company reported strong earnings growth for Q2 2025, with net income increasing to SEK44.57 million from SEK28.63 million a year ago, driven by revenue growth outpacing the Swedish market average. Despite a high level of debt and slower revenue growth forecasted at 6.4% annually, earnings are expected to grow significantly over the next three years at 21.54% per year under new CEO Magnus Andersson's leadership.

• Our expertly prepared growth report on KB Components implies its future financial outlook may be stronger than recent results.
• Click to explore a detailed breakdown of our findings in KB Components' balance sheet health report.

Semperit Holding (WBAG:SEM)

Overview: Semperit Aktiengesellschaft Holding is a global company that develops, produces, and sells rubber products for the medical and industrial sectors, with a market cap of €269.10 million.

Operations: The company's revenue primarily comes from its Semperit Engineered Applications segment, generating €364.57 million, and the Semperit Industrial Applications segment, contributing €287.20 million.

Estimated Discount To Fair Value: 15.2%

Semperit Holding is trading at €13.08, below its estimated fair value of €15.43, reflecting an undervaluation based on cash flows. Despite recent financial challenges, including a net loss of €4 million for Q2 2025 and being dropped from the S&P Global BMI Index, analysts expect the stock price to rise by 28.1%. The company is forecasted to achieve profitability within three years, with revenue growth outpacing the Austrian market average at 7.6% annually.

• The analysis detailed in our Semperit Holding growth report hints at robust future financial performance.
• Take a closer look at Semperit Holding's balance sheet health here in our report.

Summing It All Up

• Gain an insight into the universe of 208 Undervalued European Stocks Based On Cash Flows by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com